TransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024.
- Revenue
- +41.2%
- EPS
- −31.0%
- Free cash flow
- −55.4%
- Total debt
- −89.3%
Quarter to September 2026, against a year earlier
Follow TMDX
Alert me
TransMedics Group, Inc. (TMDX) Operating cash flow
TransMedics Group, Inc.'s operating cash flow for fiscal 2025 was $192.8M, up 295.1% from $48.8M in fiscal 2024. Over the twelve months to 30 September 2026 it was $112.4M. Over the past ten years it has ranged from −$45.8M (fiscal 2022) to $192.8M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. TransMedics Group, Inc. ranks 27th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $192.8M | 295.14% |
| FY2024 | $48.8M | — |
| FY2023 | −$13.0M | — |
| FY2022 | −$45.8M | — |
| FY2021 | −$28.9M | — |
| FY2020 | −$30.3M | — |
| FY2019 | −$32.3M | — |
| FY2018 | −$26.0M | — |
| FY2017 | −$23.1M | — |
| FY2016 | −$24.2M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $36.0M | 108.01% |
| Jun 2026 | $17.3M | (29.45%) |
| Mar 2026 | $24.5M | (28.92%) |
| Dec 2025 | $34.5M | (50.39%) |
| 31 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | $135.0M |
| TMDX TransMedics Group, Inc. | $112.4M |
| NEOG Neogen Corporation compare | $85.3M |
| UFPT UFP Technologies, Inc. compare | $71.6M |
| AXGN AxoGen, Inc. compare | $28.4M |
| NVCR NovoCure Limited compare | −$722.0K |
| BFLY Butterfly Network, Inc. compare | −$23.4M |
| ESTA Establishment Labs Holdings Inc. compare | −$32.3M |
| ALMR Alamar Biosciences, Inc. compare | −$100.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on TMDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement